IC

Ikarian Capital Portfolio holdings

AUM $494M
1-Year Est. Return 153.64%
This Quarter Est. Return
1 Year Est. Return
+153.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$672M
AUM Growth
+$124M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
266
New
Increased
Reduced
Closed

Top Buys

1
+$23.4M
2
+$15.9M
3
+$15.5M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$15.4M
5
RLMD icon
Relmada Therapeutics
RLMD
+$10.2M

Top Sells

1
+$29.5M
2
+$19.7M
3
+$18.8M
4
BMY icon
Bristol-Myers Squibb
BMY
+$17.9M
5
CLDX icon
Celldex Therapeutics
CLDX
+$15.8M

Sector Composition

1 Healthcare 98.54%
2 Consumer Staples 0.23%
3 Financials 0.12%
4 Industrials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
151
$383K 0.01%
115,000
152
$367K 0.01%
41,762
153
$334K 0.01%
6,039
154
$307K 0.01%
+100,000
155
$301K 0.01%
+30,000
156
$297K 0.01%
+3,600
157
$243K 0.01%
30,613
-19,548
158
$226K 0.01%
+327
159
$215K 0.01%
15,000
160
$213K 0.01%
+78,767
161
$207K 0.01%
9,553
-90,447
162
$178K 0.01%
+2,000
163
$161K 0.01%
8,076
164
$155K 0.01%
6,008
-50,000
165
$155K 0.01%
8,164
166
$153K 0.01%
+2,200
167
$151K 0.01%
2,900
-20,000
168
$131K ﹤0.01%
1,574
-50,960
169
$129K ﹤0.01%
71
170
$62K ﹤0.01%
2,000
171
$61K ﹤0.01%
1,400
172
$60K ﹤0.01%
+600
173
$56K ﹤0.01%
+603
174
$42K ﹤0.01%
+1,000
175
$23K ﹤0.01%
300
5 6
7
8 9